88393-56-0

Basic information

• Product Name: (+)-L-TARTARIC ACID DIBENZYL AMIDE
• Synonyms: (+)-L-TARTARIC ACID DIBENZYL AMIDE;N,N'-DIBENZYL (2R,3R)-2,3-DIHYDROXYSUCCINAMIDE;N,N'-DIBENZYL-L-TARTRAMIDE;(+)-N,N-Dibenzyl-L-tartaric diamide;(+)-(2R,3R)-2,3-Dihydroxy-N,N'-bis(benzyl)butanediamide;(2R,3R)-2,3-Dihydroxy-N1,N4-bis(phenylmethyl)butanediamide;(+)-N,N'-Dibenzyl-L-tartaric diaMide, 99% e.e;ButanediaMide,2,3-dihydroxy-N1,N4-bis(phenylMethyl)-, (2R,3R)-
• CAS NO: 88393-56-0
• Molecular Formula: C₁₈H₂₀N₂O₄
• Molecular Weight: 328.36
• Mol File: 88393-56-0.mol
• Article Data: 6

Chemical Properties

• Melting Point: 198-200 °C(lit.)
• Boiling Point: 706.2±60.0 °C(Predicted)
• Appearance: White/Powder
• Density: 1.279
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 11.28±0.20(Predicted)
• CAS DataBase Reference: (+)-L-TARTARIC ACID DIBENZYL AMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: (+)-L-TARTARIC ACID DIBENZYL AMIDE(88393-56-0)
• EPA Substance Registry System: (+)-L-TARTARIC ACID DIBENZYL AMIDE(88393-56-0)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 88393-56-0(Hazardous Substances Data)

Usage

General Description

(+)-L-Tartaric acid dibenzyl amide is a chemical compound derived from tartaric acid and dibenzylamine. It is a white to off-white crystalline powder and is typically used as a chiral resolving agent in organic synthesis. (+)-L-TARTARIC ACID DIBENZYL AMIDE is widely utilized in the separation of enantiomers, as it can form diastereomeric salts with chiral amines, leading to the separation of enantiomerically pure compounds. It is also used in the pharmaceutical industry as a resolving agent for chiral pharmaceuticals and in the production of fine chemicals. Additionally, it has applications in various other fields such as food, cosmetics, and agriculture. Overall, (+)-L-tartaric acid dibenzyl amide plays a critical role in the production of enantiomerically pure compounds and has a diverse range of applications in various industries.

Upstream product

• 87-69-4 tartaric acid 
• 100-46-9 benzylamine 
• 608-36-6 meso-2,3-dibromosuccinic acid 
• 7732-18-5 water 
• 133-37-9 DL-tartaric acid 
• 526-78-3 2,3-dibromosuccinic acid 
• 67-66-3 chloroform 
• 608-69-5 dimethyl D/L-tartrate 
• 608-68-4 dimethyl L-tartrate 
• 87-69-4 L-Tartaric acid 
• 87-91-2 diethyl (2R,3R)-tartrate 
• 313266-11-4 N¹,N⁴-dibenzyl-2,3-dihydroxysuccinamide 
• 88393-56-0 N,N'-dibenzyltartramide 

Downstream Products

• 32331-52-5 N-benzyl glyoxylic amide 
• 824402-15-5 (2R,3R,7R)-N,N'-dibenzyl-7-methyl-1,4-dioxa-spiro[4.14]nonadecane-2,3-dicarboxamide 
• 395644-85-6 N-benzyl-2-hydroxy-3-aminobutyric amide 
• 395644-82-3 N-benzyl-2-hydroxy-3-nitrobutyric amide 
• 460048-60-6 formic acid 1-benzylcarbamoyl-2-isocyano-propyl ester 
• 460049-36-9 N-benzyl-2-formyloxy-3-formamidobutyric amide 
• 460048-68-4 2-[(2-Acetylamino-acetyl)-(3-methyl-butyl)-amino]-4-methyl-pentanoic acid (2-benzylcarbamoyl-2-hydroxy-1-methyl-ethyl)-amide 
• 460048-66-2 3-{2-[acetylaminoacetyl-(3-methyl-butyl)-amino]-3-phenyl-propionylamino}-N-benzyl-2-hydroxy-butyramide 
• 460336-91-8 2-[((S)-2-Acetylamino-3-phenyl-propionyl)-(3-methyl-butyl)-amino]-4-methyl-pentanoic acid (2-benzylcarbamoyl-2-hydroxy-1-methyl-ethyl)-amide 
• 460336-87-2 2-[((S)-2-Acetylamino-3-phenyl-propionyl)-benzyl-amino]-4-methyl-pentanoic acid (2-benzylcarbamoyl-2-hydroxy-1-methyl-ethyl)-amide 
• 460336-89-4 3-{2-[(2-acetylamino-3-phenyl-propionyl)-(3-methyl-butyl)-amino]-3-phenyl-propionylamino}-N-benzyl-2-hydroxy-butyramide 
• 460336-85-0 3-{2-[(2-acetylamino-3-phenyl-propionyl)-benzyl-amino]-3-phenyl-propionylamino}-N-benzyl-2-hydroxy-butyramide 
• 460048-79-7 N-benzyl-N'-{[[1-(2-benzylcarbamoyl-2-hydroxy-1-methyl-ethylcarbamoyl)-3-methyl-butyl]-(3-methyl-butyl)-carbamoyl]-methyl}-succinamide 
• 460048-72-0 N-benzyl-N'-({benzyl-[1-(2-benzylcarbamoyl-2-hydroxy-1-methyl-ethylcarbamoyl)-3-methyl-butyl]-carbamoyl}-methyl)-succinamide 

Relevant articles and documents

Aldehyde-mediated bioconjugation: Via in situ generated ylides

A technically simple approach for rapid, high-yielding and site-selective bioconjugation has been developed for both in vitro and cellular applications. This method involves the generation of maleimido-phosphonium ylides via 4-nitrophenol catalysis under physiological conditions followed by their Wittig reactions with aldehyde-appended biomolecules.

COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS

The present invention relates to derivatized cyclofructan compounds, compositions comprising derivatized cyclofructan compounds, and methods of using compositions comprising derivatized cyclofructan compounds for chromatographic separations of chemical species, including enantiomers. Said compositions may comprise a solid support and/or polymers comprising derivatized cyclofructan compounds.

Synthesis of a peptidomimetic HCMV protease inhibitor library

The human cytomegalovirus (HCMV) protease catalyzes the maturational process of the herpes virus assembly protein and plays a key role during the manufacture of viral capsid, and so is an attractive target for potential anti-herpes-virus agents with novel structures and new mechanisms. In this work, a peptidomimetic skeleton was designed and a chemical library containing 32 compounds with different substitutions on the skeleton was prepared by the oxidation of a precursor library, which was constructed from four types of building blocks: 4 carboxylic acids, 2 amines, 2 aldehydes and 2 isocyanides, based on multicomponent condensation following liquid phase strategies. The syntheses of the key building block isocyanides are presented.